Sunday, October 11

7:00 am - 6:00 pm

Registration Open

7:00 am - 8:45 am

Breakfast on your own*

* Registrants will be notified if a corporate-supported symposium is offered during this time slot.

8:45 am - 9:45 am

Exhibits Open

10:00 am - 11:30 am

Concurrent Sessions (111-114)

111

Phosphorous Pyramid

1.5 CH1.5 RxRN

Robin Russell, MS, RD, CSR, LD

  • Recall the importance of phosphorous restriction and identify strategies that may reduce dietary phosphorous intake.
  • Identify optimal nutrition education methods for effective management of hyperphosphatemia in hemodialysis patients.
  • Describe the Phosphorous Pyramid as a novel educational tool for dietary counseling.
  • Review the importance of identifying and understanding health beliefs when addressing dietary adherence in order to effectively manage hyperphosphatemia.

112

Using Evidence to Decrease the Incidence of Infections in Nephrology Patient Populations

1.5 CHHT

Tamara Kear, PhD, RN, CNS, CNN
Beth Ulrich, EdD, RN, FACHE, FAAN

  • Discuss findings related to infection control from the first national survey of patient safety culture in nephrology nurse practice settings.
  • Investigate evidence related to infection control practices in nephrology nurse practice settings.
  • Explore the ways that evidence can be used to address commonly described infection control infringements in nephrology nurse practice.

113

Nephrology Nursing Sensitive Quality Indicators (NNSQIs)

1.5 CHMGMT

Carolyn Latham, MSN, MBA, RN, CNN
Charlotte Thomas-Hawkins, PhD, RN
Debra Hain, PhD, ARNP, ANP-BC, GNP-BC, FAANP

  • Define nephrology nursing sensitive quality indicators (NNSQIs).
  • Explain the necessity of utilizing NNSQIs.
  • Analyze the current state of development of NNSQIs.

114

Immunization: Get Your Shots!

1.5 CH1.5 RxHT

Erica Crannage, PharmD, BCPS, BCACP

  • Define the recommended immunization schedule for individuals of all ages with CKD.
  • Describe the immunogenicity and duration of immunity in individuals with CKD.
  • Discuss the indications for use of live attenuated versus inactivated vaccines in individuals with CKD.

11:30 am - 12:30 pm

Exhibits Open

12:30 pm - 2:45 pm

Lunch on your own*

Registrants will be notified if a corporate-supported symposium is offered during this time slot.

2:45 pm - 4:15 pm

Concurrent Sessions (131-134)

131

Cognitive Impairment: Where did I leave my... ?

1.5 CHRN

Debra Hain, PhD, ARNP, ANP-BC, GNP-BC, FAANP

  • Describe the scope of cognitive impairment in individuals with CKD.
  • Outline key aspects of cognitive function assessment.
  • Examine how cognitive function affects decision-making capacity.
  • Propose interventions to enhance self-care in individuals with impaired cognitive function.

132

Hypertension: Guideline Confusion

1.5 CH1.5 RxAPN

Wendy St. Peter, FCCP, FASN, FNKF

  • Compare the JNC 7 and JNC 8 treatment guidelines for hypertension.
  • Analyze the studies that provide evidence to the changes recommended in JNC 8.
  • Select the appropriate medication for treatment of hypertension based on JNC 8 guidelines.

133

Reaching for the Stars: Five-Star Quality Rating System

1.5 CHMGMT

Elena Balovlenkov, MS, RN

  • Describe the development of the Centers for Medicare & Medicaid Systems (CMS) Five-Star Quality Rating System.
  • Examine the criteria used in the Five-Star Quality Rating System.
  • Rate their personal facility using the Five-Star Quality Rating System.

134

Transplant: Managing the Waiting List

1.5 CHHT

Sharon Longton, BSN, RN, CNN, CCTC

  • Discuss the transplant waiting list candidacy process.
  • Describe essential information needed to ensure patient readiness for transplant.
  • Develop a plan for patients awaiting a transplant.

4:30 pm - 6:00 pm

Concurrent Sessions (141-144)

141

Transplant Tourism: You Got your Kidney from Where?

1.5 CHRN

Karin True, MD

  • Define transplant tourism.
  • Discuss risks associated with transplant tourism.
  • Apply strategies to address the risks associated with transplant tourism.

142

Counterfeit Drugs

1.5 CH1.5 RxAPN

Tracy Anderson-Haag, PharmD, BCPS

  • Relate how the increased prevalence of counterfeit drugs may affect patient therapy.
  • Develop a plan to include medication source information in patient assessments.
  • Summarize a plan for teaching patients and other health care professionals about how to evaluate the source of medication purchases for legitimacy in order to prevent inadequate response to the medical regimen.

143

Developing and Recognizing Professionalism in the Workplace

1.5 CHMGMT

Carol Headley, DNSc, ACNP, RN, CNN

  • Explore professionalism.
  • Develop strategies to enhance professionalism in the work environment.

144

Renal Failure and Burns

1.5 CHHT

Mario Rivera, MAJ AN, BSN, RN

  • Discuss the pathophysiologic changes that contribute to acute kidney injury (AKI) in an individual with burns.
  • Implement strategies to prevent AKI in an individual with burns.
  • Identify treatment strategies for an individual with burns and AKI.

> View the schedule for Saturday View the schedule for Monday >